S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
Log in
NASDAQ:BNTX

BioNTech News Headlines

$104.96
+3.09 (+3.03 %)
(As of 11/25/2020 05:14 PM ET)
Add
Compare
Today's Range
$99.10
Now: $104.96
$106.06
50-Day Range
$77.54
MA: $92.50
$112.76
52-Week Range
$20.49
Now: $104.96
$115.00
Volume2.98 million shs
Average Volume2.15 million shs
Market Capitalization$23.75 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

BioNTech (NASDAQ BNTX) News Headlines Today

Source:
SourceHeadline
How to Invest After a Turbulent 2020 Election (BNTX)How to Invest After a Turbulent 2020 Election (BNTX)
marketbeat.com - November 23 at 5:51 PM
COVID-19 Vaccine Results See AstraZeneca (LON:AZN) Slip a Bit (BNTX)COVID-19 Vaccine Results See AstraZeneca (LON:AZN) Slip a Bit (BNTX)
marketbeat.com - November 19 at 12:08 PM
BioNTech scientist: Vaccine could halve virus transmissionBioNTech scientist: Vaccine could halve virus transmission
marketbeat.com - November 15 at 12:18 PM
AstraZeneca Still a Buy as Its Coronavirus Vaccine Looks at a Fast Track (BNTX)AstraZeneca Still a Buy as Its Coronavirus Vaccine Looks at a Fast Track (BNTX)
marketbeat.com - August 24 at 10:10 AM
Moderna (NASDAQ: MRNA) Set to Open Up Higher on US Government Deal for Vaccine (BNTX)Moderna (NASDAQ: MRNA) Set to Open Up Higher on US Government Deal for Vaccine (BNTX)
marketbeat.com - August 12 at 8:09 AM
History Shows Why Pfizer Needs Its Vaccine Candidate to Grow (BNTX)History Shows Why Pfizer Needs Its Vaccine Candidate to Grow (BNTX)
marketbeat.com - August 3 at 2:09 PM
Moderna (NASDAQ: MRNA) Makes Gains on Phase 3 Testing (BNTX)Moderna (NASDAQ: MRNA) Makes Gains on Phase 3 Testing (BNTX)
marketbeat.com - August 3 at 2:09 PM
AstraZeneca (LON:AZN) Follows Up its COVID-19 Progress to Take on an Even Bigger Killer (BNTX)AstraZeneca (LON:AZN) Follows Up its COVID-19 Progress to Take on an Even Bigger Killer (BNTX)
marketbeat.com - August 3 at 2:09 PM
Pfizer (PFE), BioNTech BNTX) Land Multi-Billion Dollar Order for Vaccine (BNTX)Pfizer (PFE), BioNTech BNTX) Land Multi-Billion Dollar Order for Vaccine (BNTX)
marketbeat.com - August 3 at 2:09 PM
AstraZenecas (LON:AZN) Results Disappoint, Resiliency Makes it Worth a Buy (BNTX)AstraZeneca's (LON:AZN) Results Disappoint, Resiliency Makes it Worth a Buy (BNTX)
marketbeat.com - August 3 at 2:09 PM
Pfizer (PFE) Looks Like a Buy as Vaccine Chances Surge (BNTX)Pfizer (PFE) Looks Like a Buy as Vaccine Chances Surge (BNTX)
marketbeat.com - August 3 at 2:09 PM
3 Companies to Bet On as the World Races For a Vaccine (BNTX)3 Companies to Bet On as the World Races For a Vaccine (BNTX)
marketbeat.com - August 3 at 2:08 PM
Redfield: CDC will have shortened quarantine guidelines in a weekRedfield: CDC will have shortened quarantine guidelines in a week
finance.yahoo.com - November 25 at 1:29 PM
Moderna’s Final Covid Vaccine Results Are Imminent. Billions in Revenue Will Follow, Goldman Says.Moderna’s Final Covid Vaccine Results Are Imminent. Billions in Revenue Will Follow, Goldman Says.
finance.yahoo.com - November 25 at 1:29 PM
BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies - GlobeNewswireBioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies - GlobeNewswire
globenewswire.com - November 25 at 8:28 AM
Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine - Yahoo FinancePfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine - Yahoo Finance
finance.yahoo.com - November 24 at 10:28 PM
BioNTech (NASDAQ:BNTX) Given New $91.00 Price Target at SVB LeerinkBioNTech (NASDAQ:BNTX) Given New $91.00 Price Target at SVB Leerink
americanbankingnews.com - November 24 at 8:32 AM
Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 VaccinePfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine
finance.yahoo.com - November 24 at 7:19 AM
What Investors Need To Know About Pfizers Coronavirus Vaccine And Ultra-Cold Storage RequirementsWhat Investors Need To Know About Pfizer's Coronavirus Vaccine And Ultra-Cold Storage Requirements
finance.yahoo.com - November 24 at 7:19 AM
With Pfizer Partnership, BioNTech Stock Should Push Higher - InvestorPlaceWith Pfizer Partnership, BioNTech Stock Should Push Higher - InvestorPlace
investorplace.com - November 24 at 2:19 AM
Why BioNTech and Moderna Will Trade at New Highs - Baystreet.caWhy BioNTech and Moderna Will Trade at New Highs - Baystreet.ca
baystreet.ca - November 23 at 9:18 PM
Too Early to Call BioNTech the Winner in the COVID-19 Vaccine Race, Says Analyst - Yahoo FinanceToo Early to Call BioNTech the Winner in the COVID-19 Vaccine Race, Says Analyst - Yahoo Finance
finance.yahoo.com - November 23 at 9:18 PM
Decision on approving Pfizer-BioNTech vaccine to be made in shortest time possible, U.K. regulator says - MarketWatchDecision on approving Pfizer-BioNTech vaccine to be made in 'shortest time possible,' U.K. regulator says - MarketWatch
marketwatch.com - November 23 at 9:18 PM
Too Early to Call BioNTech the Winner in the COVID-19 Vaccine Race, Says AnalystToo Early to Call BioNTech the Winner in the COVID-19 Vaccine Race, Says Analyst
finance.yahoo.com - November 23 at 9:18 PM
At least one sell-sider not impressed with AstraZeneca COVID-19 results; AZN slips, while Pfizer, BioNTech, Moderna gainAt least one sell-sider not impressed with AstraZeneca COVID-19 results; AZN slips, while Pfizer, BioNTech, Moderna gain
seekingalpha.com - November 23 at 11:15 AM
AstraZeneca COVID-19 results dont impress Wall Street, while Pfizer, BioNTech, Moderna gainAstraZeneca COVID-19 results don't impress Wall Street, while Pfizer, BioNTech, Moderna gain
seekingalpha.com - November 23 at 11:15 AM
Why BioNTech and Moderna Will Trade at New HighsWhy BioNTech and Moderna Will Trade at New Highs
marketwatch.com - November 23 at 11:15 AM
U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infectionsU.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections
finance.yahoo.com - November 23 at 11:15 AM
AstraZeneca vaccine is ‘highly suitable for people in the U.S. & Europe’: AstraZeneca execAstraZeneca vaccine is ‘highly suitable for people in the U.S. & Europe’: AstraZeneca exec
finance.yahoo.com - November 23 at 11:15 AM
AstraZeneca-Oxford COVID-19 vaccine can be up to 90% effective, late-stage trials showAstraZeneca-Oxford COVID-19 vaccine can be up to 90% effective, late-stage trials show
finance.yahoo.com - November 23 at 6:14 AM
Is Pfizer and BioNTechs Potential mRNA Coronavirus Vaccine Revolutionary? - The Motley FoolIs Pfizer and BioNTech's Potential mRNA Coronavirus Vaccine Revolutionary? - The Motley Fool
fool.com - November 22 at 5:50 PM
What This Virus Expert Thinks About mRNA Vaccine Candidates for COVID-19What This Virus Expert Thinks About mRNA Vaccine Candidates for COVID-19
finance.yahoo.com - November 22 at 7:49 AM
Why Ultra-Cold Storage and Two-Dose Shots Could Spell A Logistical Nightmare for PfizerWhy Ultra-Cold Storage and Two-Dose Shots Could Spell A Logistical Nightmare for Pfizer
finance.yahoo.com - November 22 at 7:49 AM
Moderna and BioNTech Looking at Imminent EU Vaccine Approval - TheStreetModerna and BioNTech Looking at Imminent EU Vaccine Approval - TheStreet
thestreet.com - November 22 at 2:48 AM
A Doctor Explains: What Pfizers Big Coronavirus Vaccine News MeansA Doctor Explains: What Pfizer's Big Coronavirus Vaccine News Means
finance.yahoo.com - November 21 at 11:47 AM
BioNtech and Moderna Vaccines May Get Emergency Use Approval In Europe - BenzingaBioNtech and Moderna Vaccines May Get Emergency Use Approval In Europe - Benzinga
benzinga.com - November 21 at 6:47 AM
Pfizer, BioNTech make it official: COVID-19 vaccine EUA submitted - MarketWatchPfizer, BioNTech make it official: COVID-19 vaccine EUA submitted - MarketWatch
marketwatch.com - November 21 at 6:47 AM
Pfizer, BioNTech file for emergency use authorization for COVID-19 vaccine - Yahoo TechPfizer, BioNTech file for emergency use authorization for COVID-19 vaccine - Yahoo Tech
finance.yahoo.com - November 20 at 11:02 PM
BioNTech (NASDAQ:BNTX) Trading Up 9.6%BioNTech (NASDAQ:BNTX) Trading Up 9.6%
americanbankingnews.com - November 20 at 6:33 PM
Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday - MarketWatchPfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday - MarketWatch
marketwatch.com - November 20 at 6:02 PM
Pfizer, BioNTech make it official: COVID-19 vaccine EUA submittedPfizer, BioNTech make it official: COVID-19 vaccine EUA submitted
finance.yahoo.com - November 20 at 6:02 PM
Maravai IPO Raises $1.62 Billion For Provider Of Drug-Testing ServicesMaravai IPO Raises $1.62 Billion For Provider Of Drug-Testing Services
finance.yahoo.com - November 20 at 1:02 PM
Dow Jones Lags As Market Rally Pauses; Nasdaq On Track For Weekly GainDow Jones Lags As Market Rally Pauses; Nasdaq On Track For Weekly Gain
finance.yahoo.com - November 20 at 1:02 PM
BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDABioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA
finance.yahoo.com - November 20 at 1:02 PM
Pfizer, BioNTech Plan to File on Friday to Use Vaccine in December - BloombergPfizer, BioNTech Plan to File on Friday to Use Vaccine in December - Bloomberg
bloomberg.com - November 20 at 8:01 AM
EU Could Approve BioNTech, Moderna Vaccines in December - BloombergEU Could Approve BioNTech, Moderna Vaccines in December - Bloomberg
bloomberg.com - November 20 at 3:01 AM
Norwegian Air Shuttle Flew Too Close to the SunNorwegian Air Shuttle Flew Too Close to the Sun
finance.yahoo.com - November 20 at 3:01 AM
Heres Whats Bumping BioNTech Stock Higher Today - The Motley FoolHere's What's Bumping BioNTech Stock Higher Today - The Motley Fool
fool.com - November 19 at 10:00 PM
Pfizer/BioNTech vs. Moderna: Which Covid-19 Vaccine Has the Upper Hand?Pfizer/BioNTech vs. Moderna: Which Covid-19 Vaccine Has the Upper Hand?
finance.yahoo.com - November 19 at 10:00 PM
BioNTech CEO Says Coronavirus Vaccine Could Be Home For ChristmasBioNTech CEO Says Coronavirus Vaccine Could Be Home For Christmas
finance.yahoo.com - November 19 at 4:59 PM
Hedge funds sold Moderna, BioNtech shares before vaccine news - Yahoo FinanceHedge funds sold Moderna, BioNtech shares before vaccine news - Yahoo Finance
finance.yahoo.com - November 19 at 11:59 AM
Major Indices Fall Despite Positive Coronavirus Vaccine DataMajor Indices Fall Despite Positive Coronavirus Vaccine Data
finance.yahoo.com - November 19 at 11:59 AM
Vaccines Fight Covid, But Can They Stop the Spread?Vaccines Fight Covid, But Can They Stop the Spread?
finance.yahoo.com - November 19 at 11:59 AM
Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%
finance.yahoo.com - November 19 at 11:59 AM
It’s ‘extremely urgent’ Congress passes another stimulus bill to help hospitals: CEOIt’s ‘extremely urgent’ Congress passes another stimulus bill to help hospitals: CEO
finance.yahoo.com - November 19 at 11:59 AM
QIAGEN (QGEN), BioNTech to Develop Test to Identify SCCHNQIAGEN (QGEN), BioNTech to Develop Test to Identify SCCHN
finance.yahoo.com - November 19 at 11:59 AM
BioNTech CEO predicts a return to normalcy in 2021 - CNNBioNTech CEO predicts a return to normalcy in 2021 - CNN
cnn.com - November 18 at 11:01 PM
Wednesday Morning Stock Market Movers: Boeing, Target, Pfizer, BioNTech - BarronsWednesday Morning Stock Market Movers: Boeing, Target, Pfizer, BioNTech - Barron's
barrons.com - November 18 at 5:59 PM
BioNTech and Pfizer will seek emergency US authorization for vaccine on Friday, CEO says - CNNBioNTech and Pfizer will seek emergency US authorization for vaccine on Friday, CEO says - CNN
cnn.com - November 18 at 5:59 PM
Pfizer (PFE), BioNTech (BNTX) vaccine is 95% effective in final analysis - Seeking AlphaPfizer (PFE), BioNTech (BNTX) vaccine is 95% effective in final analysis - Seeking Alpha
seekingalpha.com - November 18 at 7:58 AM
Why Inovio Shares Are Slumping When BioNTech And Moderna Are Surging - Seeking AlphaWhy Inovio Shares Are Slumping When BioNTech And Moderna Are Surging - Seeking Alpha
seekingalpha.com - November 18 at 7:58 AM
Pfizer Is Very Close To Seeking OK For Coronavirus VaccinePfizer Is 'Very Close' To Seeking OK For Coronavirus Vaccine
finance.yahoo.com - November 17 at 6:14 PM
This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.